| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |